Los medicamentos con semaglutida, como Ozempic, Wegovy y Rybelsus, se han popularizado en todo el mundo como la “fórmula milagro” para perder peso rápidamente. Sin embargo, la Agencia Europea del Medicamento (EMA) ha confirmado que estos fármacos pueden provocar, en casos muy poco frecuentes, pérdida súbita de visión por una enfermedad llamada neuropatía óptica isquémica […]| OpenSportlife
Across the country, one in eight adults has taken a medication like Ozempic, according to a KFF poll from last year, and even more people are learning about it. The same poll found that about one-third of all adults have heard “a lot” about these drugs. Recent news about Ozempic seems to include a lot of claims about what it may be able to treat in addition to diabetes and obesity. Some experts are concerned, though, that studies into new applications of the drug may be driven by dishones...| Scienceline
The Princeton researcher has published a book in which she reviews what is known about the science of living longer and healthier lives| EL PAÍS English
Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide.| Global News
Is it too late to welcome in the new year? At the beginning of January, 87% of people resolve to get healthier.* Most of them are looking to lose weight. I was one of those people last year. I reached a high of 197 pounds shortly after Thanksgiving. At 5 feet, 8 inches, that’s a […]| Lazy Man and Money
Les médicaments comme Ozempic permettent de perdre de 15 % à 25 % de notre poids. Ce traitement doit toutefois être accompagné d'une évaluation attentive, puis d'une prise en charge et surtout d'un suivi étroit et régulier impliquant l'alimentation, l'activité physique, la santé mentale et, si besoin, une assistance sur le plan socioéconomique.| L’actualité
Glucagon-like peptide 1, or GLP-1, agonists are all the rage right now thanks to drugs like Ozempic and Wegovy. Though they’re currently being prescribed for diabetes and weight loss, a Houston company reports that it may have found another use for GLP-1s.| InnovationMap
Ozempic and other GLP-1 receptor agonists have skyrocketed in popularity as a treatment for obesity, promising rapid weight-loss at a hefty price. “Miracle drug” is one of the descriptors use by celebrities, influencers, and many journalists. I have so far held off on first-hand experience (Related read: No Biological Free Lunches), and I suggest reading […]| The Blog of Author Tim Ferriss
What is Ozempic or Mounjaro? Weight Loss Medication is available for Type 2 Diabetes, Obesity, or high BMI with other co-morbid indications.| The Kellie Kitchen